Angles 2

Date: Friday 30 September 2022

Time: 15.30-16.00

Tamar Nijsten did his medical and dermatology training in Antwerp (Belgium). He joined Prof. Robert Stern at Harvard Medical School and to study the carcinogenic effects of PUVA therapy in psoriasis patients between 2001-2003. For this research project he received a Fulbright scholarship and a grant from the Flanders Scientific Organization. In 2004, he received a PhD in medicine at the University of Antwerp. After completing his residency in dermatology in 2005, he joined the department of dermatology at the Erasmus MC (Rotterdam, The Netherlands). At the Erasmus MC, he started the dermato-epidemiology research group. Fifteen years later, this is a well respected group that consists of over 20 PhD students, several postdocs, assistant and associate professors focusing on a variety of skin diseases. This is reflected in more than 360 peer-reviewed publications and an H-index > age. In 2010, Tamar Nijsten received a Vidi-grant to explore the genetics of basal cell carcinoma. Tamar Nijsten introduced dermatology to the existing population based cohorts in Rotterdam (i.e., Rotterdam Study and Generation R). In addition to his research, he sees patients and supervises residents at the Erasmus MC. He is active in (inter)national dermatological organisations including the EADV, ESDR and EDEN and has given plenary lectures at their meetings. Tamar Nijsten was section editor for J Invest Dermatol and is it currently for the Br J Dermatol. Between 2012-2015, he was chair of the Dutch Society of Dermatology and Venereology. He has been appointed professor in dermatology at the Erasmus MC since 2012 with a special focus on public health and epidemiology followed by the chair position in 2014.